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Abstract
Background: Timely recognition of the end of life allows patients to discuss preferences and make advance plans,
and clinicians to introduce appropriate care. We examined changes in frailty over 1 year, with the aim of identifying
trajectories that could indicate where an individual is at increased risk of all-cause mortality and may require
palliative care.
Methods: Electronic health records from 13,149 adults (cases) age 75 and over who died during a 1-year period
(1 January 2015 to 1 January 2016) were age, sex and general practice matched to 13,149 individuals with no record
of death over the same period (controls). Monthly frailty scores were obtained for 1 year prior to death for cases, and
from 1 January 2015 to 1 January 2016 for controls using the electronic frailty index (eFI; a cumulative deficit measure
of frailty, available in most English primary care electronic health records, and ranging in value from 0 to 1). Latent
growth mixture models were used to investigate longitudinal patterns of change and associated impact on mortality.
Cases were reweighted to the population level for tests of diagnostic accuracy.
Results: Three distinct frailty trajectories were identified. Rapidly rising frailty (initial increase of 0.022 eFI per month
before slowing from a baseline eFI of 0.21) was associated with a 180% increase in mortality (OR 2.84, 95% CI 2.34–3.45)
for 2.2% of the sample. Moderately increasing frailty (eFI increase of 0.007 per month, with baseline of 0.26) was
associated with a 65% increase in mortality (OR 1.65, 95% CI 1.54–1.76) for 21.2% of the sample. The largest (76.6%)
class was stable frailty (eFI increase of 0.001 from a baseline of 0.26). When cases were reweighted to population level,
rapidly rising frailty had 99.1% specificity and 3.2% sensitivity (positive predictive value 19.8%, negative predictive value
93.3%) for predicting individual risk of mortality.
Conclusions: People aged over 75 with frailty who are at highest risk of death have a distinctive frailty trajectory in the
last 12 months of life, with a rapid initial rise from a low baseline, followed by a plateau. Routine measurement of frailty
can be useful to support clinicians to identify people with frailty who are potential candidates for palliative care, and
allow time for intervention.
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Background
An increasing number of older people are now dying with
a diagnosis of frailty. In high-income countries, the esti-
mated prevalence of frailty is 11% for people aged over 65
years, rising to 25–50% for people over 85 [1]. Frailty is
characterised by an accumulation of deficits and reduced
strength, endurance and physiological function [2, 3]. It is
associated with a range of adverse outcomes, including
falls, delirium, disability and mortality [4–8].
Timely recognition of the end-of-life phase is funda-
mental to the provision of palliative care, as it allows cli-
nicians to introduce generalist or specialist services, to
discuss preferences and make advance plans [9–11]. This
may be particularly challenging for patients with frailty,
where trajectories of decline are gradual and slow, and
patients may not have a recognised life-limiting diagno-
sis [12, 13]. Despite calls for greater awareness of the
benefits of palliative care for people with frailty [14], rec-
ognition remains incomplete [15].
Since 2017, general practitioners (GPs) in England have
been required to identify and review patients with moderate
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and severe frailty using an appropriate tool. One of the
instruments recommended by NHS England is the elec-
tronic frailty index (eFI) [16, 17]. The eFI is a cumulative
deficit measure of frailty that uses over 2000 Read codes
to calculate a frailty score based on a variety of symptoms,
diagnoses and observations recorded in primary care
electronic health records [5]. It is available in GP software
systems in the UK, and can be calculated automatically
from patients’ records at any time. Previous research has
shown that frailty measured by the eFI at a single time
point can predict mortality at a population level [17], but
it is not effective at identifying individuals at short-term
risk of all-cause mortality before this would be clinically
apparent [18]. Frailty is associated with increasing age, but
there is also wide inter-individual variation in how deficits
are accumulated over time, and studies have demonstrated
different longitudinal trajectories of frailty [19, 20]. How-
ever, to date, few studies have examined the association
between longitudinal change in frailty and mortality.
Where studies have been carried out, they have produced
population level results with limited clinical application.
For example, recent analysis of data from a US cohort
identified distinct frailty trajectories and their associated
mortality risk, using scores calculated at annual intervals
over 8 years [21].
In this study, we used eFI measured at monthly inter-
vals to examine longitudinal change in frailty in the year
before death. The aim was to determine if changes in
frailty measured by the eFI could be useful in primary




The study population was sampled by ResearchOne
from their health and care research database, containing
de-identified clinical and administrative data from ap-
proximately six million active electronic healthcare re-
cords. ResearchOne extracts anonymised data from the
SystmOne clinical information system, which is used in
over 35% (2500) of general practices in England, and
holds records on approximately half of the UK popula-
tion. Primary care professionals use SystmOne to record
their consultations (including patient histories, clinical
observations, diagnoses, treatments and referrals) with
free text and the Read code classification system.
Participants
ResearchOne identified records of individuals (cases)
aged 75 years and over who died between 1 January
2015 and 1 January 2016. A comparison group (controls)
was constructed by identifying patients matched 1:1 to
cases by age, sex and practice location, but with no rec-
ord of death between 1 January 2015 and 1 January
2016. Patients without eFI scores, those with records
available for fewer than 6 months, and those for whom
cause of death was classified as an external cause of
mortality (accidents, suicides, murders according to
International Classification of Diseases codes version 10)
were excluded.
Study design
In this longitudinal study, the relationship between mor-
tality and frailty was determined using eFI scores gener-
ated at monthly intervals for 1 year prior to recorded
month of death for cases, and 1 year prior to 1 January
2016 for matched controls. Controls were matched at
age of death of the case (between 1 January 2015 and 1
January 2016), and sampled on 1 January 2016, when
they were known to have survived; hence, controls were,
on average, 6 months older than the cases at time of
measurement. Approval for this study was granted by
the ResearchOne ethical review panel, with oversight
from the UK NHS Health Research Authority and the
UK Government Health and Social Care Information
Centre Confidentiality Advisory Group. ResearchOne
was approved by the UK NHS National Research Ethics
Service (11/NE/0184).
Measurements
The eFI is a cumulative deficit measure of frailty that
calculates a frailty score based on 36 deficits, drawn
from a pool of 2000 clinical Read codes for symptoms,
signs, diseases, disabilities and abnormal laboratory test
values. An individual’s eFI score is calculated by dividing
the number of deficits present by the total possible to
create a score between zero (no deficits) and one (36
deficits) [17]. In this study, eFI was calculated automatic-
ally by ResearchOne at monthly intervals for 1 year,
based on the information contained in each participant’s
clinical record.
Analysis
Latent growth curve models were used to examine the
shape of change in eFI and the relationship between eFI
trajectory and age and sex (age mean centred and female
as the referent categories). Latent class growth mixture
models were used to examine the potential for sub-
groups (classes) of the population to have different tra-
jectories of change in eFI. The optimum number of
classes was determined using sample size-adjusted
Bayesian information criterion (BIC) and model entropy.
The trajectories estimated from the optimum latent class
growth mixture model were used to examine the associ-
ation between class membership and mortality (case/
control status) as a distal outcome [22]. The longitudinal
models were formulated using months as the time vari-
able, with month 0 as baseline and month 12 at death/
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study end. All longitudinal models were run in Mplus
version 8 (Muthén & Muthén, Los Angeles, CA, USA).
To estimate the proportions of the population in each of
the trajectory classes, adjusting for the study design
(sample of controls), the posterior probabilities for being
in each class were reweighted by the population esti-
mates from Office of National Statistics life tables.
Weighted class sizes and the association between class
membership and mortality were calculated using the
Survey package (Lumley, 2017) in R version 3.4.2 (R
Core team, Vienna, Austria).
Results
This study analysed information on 26,298 individuals
(13,149 cases and 13,149 controls), 14,620 (55.6%) of
whom were female and 11,678 (44.4%) were male. The
mean age at death for cases was 85.14 (SD 5.98) years
with a pseudo age of 85.66 (SD 5.98) years for controls,
as expected by design. Age-adjusted mean eFI at baseline
was significantly higher (p < 0.001) for cases (eFI = 0.27,
9.8 deficits) than for controls (eFI = 0.23, 8.3 deficits), as
expected from previous work [17, 18], and mean eFI for
females (eFI = 0.23, 8.3 deficits) was significantly higher
(p < 0.001) at baseline than for males (eFI = 0.22, 8.0 defi-
cits) when adjusted for age and case/control status.
Table 1 shows the demographic characteristics of the
study sample.
The latent growth curve model that best described the
shape of frailty change over the study period included
freely estimated intercepts, slopes and a quadratic poly-
nomial term for time (see Additional file 1: Table S1 for
parameter descriptions and model fit statistics). The esti-
mated mean trajectory of eFI increased by 0.002 (95% CI
0.001–0.002, 0.1 deficits) per month (at study baseline)
from a mean of 0.252 (95% CI 0.251–0.253, 9.1 deficits).
The quadratic term was small (eFI = 0.00003, 95% CI
0.00003–0.00004) but improved the model fit and was
retained to allow flexibility in class structures during the
mixture modelling phase. Large variance in the intercept
(eFI = 0.128) and slope (eFI = 0.278) was observed, sug-
gesting individual heterogeneity in trajectories. There
was some evidence that higher baseline frailty was re-
lated to slower frailty increase over time (intercept slope
covariance − 0.109, p < 0.006).
The quadratic model was extended to investigate the
impact of age and sex on the trajectories (Table 2 and
Additional file 1: Table S2 for model fit and parameter
descriptions). In the full model (Additional file 1: Table
S2), eFI at study baseline increased by 0.0047 (95% CI
0.0044–0.0049, 0.2 deficits; p < 0.001) for each year of
age, and men had a mean eFI of 0.0016 (95% CI
0.00133–0.00187, 0.6 deficits; p < 0.001) lower than
women. Because there was little evidence that sex or age
influenced the trajectory of frailty over time (for each
year of age, eFI increased by 0.00002 per month, 95% CI
0.00001–0.00003, < 0.001 deficits, p = 0.003, all other co-
efficients p > 0.05), the model regressing the intercept
only on age and sex, including slopes and quadratic
terms (Table 2), was carried forward to investigate po-
tential latent class trajectories.
A three-class latent growth mixture model model (Table
2) was chosen as the most parsimonious with good fit and
clinically relevant classes (Additional file 1: Table S3). The
most common ‘stable’ class contained 76.6% of the sample
and showed little change in frailty over time, with eFI in-
creasing by 0.001 per month (0.04 deficits, ‘stable’ class)
from a baseline eFI of 0.260 (9.4 deficits). A ‘moderate
growth’ class containing 21.2% of the sample demonstrated
an eFI increase of 0.0045 (0.2 deficits) per month from a
slightly higher baseline eFI of 0.262 (9.4 deficits), and a
small ‘rapidly rising’ class containing 2.2% of the sample
showed a sharp, distinct increase in eFI of 0.01 per month
(0.4 deficits) on average over the year from a lower baseline
eFI of 0.206 (7.4 deficits). The majority of individuals in
this class accrued deficits quickly, with a 0.02 eFI increase
per month over the first 3 months (s = 0.023, 95% CI
0.021–0.025), but the quadratic component (q = − 0.001,
95% CI – 0.001 to – 0.001) indicates that they then experi-
enced a period of relative stability; this group had an aver-
age increase in eFI over 1 year 14 times higher than the
stable class. Age and sex were associated with baseline
frailty (eFI = 0.005/0.2 deficits per year of age, eFI = 0.016/
0.6 deficits higher for women) across classes, but were
only weakly related to class membership (all ORs approxi-
mately 1.0).
Compared with the ‘stable’ class both the ‘rapidly ris-
ing’ class (OR 2.84, 95% CI 2.34–3.45) and the ‘moderate
growth’ class (OR 1.65, 95% CI 1.54–1.76) were found to
be associated with mortality. Figure 1 displays the mean




Female (n, %) 7310 55.59 7310 55.59
Male (n, %) 5839 44.41 5839 44.41
Age, years (mean, SD) 85.14 5.98 85.66 5.98
Female age, years (mean, SD) 86.15 6.11 86.68 6.12
Male age, years (mean, SD) 83.87 5.55 84.38 5.54
eFI 27.05 23.27
Female eFI 28.08 24.61
Male eFI 25.76 21.59
eFI (age adjusted) 27.18 23.13
Female eFI (age adjusted) 27.87 23.84
Male eFI (age adjusted) 26.30 22.27
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and observed individual trajectories for each class and
the association between class and mortality risk.
To understand the population characteristics, the
posterior probabilities for being in each class were
reweighted to reflect the general population. Compared
with the ‘stable class’, both the ‘rapidly rising’ class (OR
3.02, 95% CI 2.49–3.65) and the ‘moderate growth’ class
(OR 1.58, 95% CI 1.49–1.67) were associated with an in-
creased chance of mortality. Table 3 contains demo-
graphic information for the members of each class.
Reweighting the controls to the population suggests that
1.1% of the population exhibited rapidly rising frailty;
using this group to predict mortality within the year was
highly specific (99.1% specificity), with 19.8% positive
predictive value and 93.3% negative predictive value, but
with low sensitivity (3.2%). Addition of the ‘moderately
increasing’ class increased the sensitivity (27.8%) and
negative predictive value (93.9%) at the expense of a de-
creased specificity (82.3%) and positive predictive value
(10.4%).
Table 2 Summary of best fitting models for shape of change, the impact of study covariates and class descriptions
Model Latent growth model: Intercept
variance free, slope variance
free, quadratic term added
Previous model plus study design
covariates age and sex, intercept
regressed on age and sex
Previous model specified as a
latent growth mixture model
with three classes
Log likelihood − 530,331.072 −529,340.060 − 519,497.615
Adjusted BIC 1,060,816.13 1,058,848.110 1,039,247.203
Estimatea 95% CI Estimatea 95% CI Estimatea 95% CI
Intercept 25.185 (25.048 to 25.322) 25.893 (25.715 to 26.071) class 1 ‘stable class’
(n = 20,144, 76.6%)
25.959 (25.763 to 26.155)
Slope 0.151 (0.144 to 0.158) 0.151 (0.144 to 0.158) − 0.080 (− 0.085 to – 0.074)
Quadratic 0.003 (0.003 to 0.004) 0.003 (0.003 to 0.004) 0.015 (0.015 to 0.015)
Age on intercept – – 0.467 (0.444 to 0.489) 0.466 (0.444 to 0.489)
Sex on intercept – – − 1.594 (− 1.864 to – 1.325) − 1.598 (− 1.866 to – 1.329)
Intercept class 2 ‘moderately
increasing class’
(n = 5572, 21.2%)
26.232 (25.907 to 26.558)
Slope 0.802 (0.765 to 0.838)
Quadratic − 0.029 (− 0.032 to – 0.027)
Age on intercept 0.466 (0.444 to 0.489)
Sex on intercept − 1.598 (− 1.866 to – 1.329)
Intercept class 3 ‘rapidly rising
class’ (n = 582, 2.2%)
20.583 (19.387 to 21.779)
Slope 2.294 (2.115 to 2.472)
Quadratic mean − 0.102 (− 0.114 to – 0.09)
Age on intercept 0.466 (0.444 to 0.489)
Sex on intercept − 1.598 (− 1.866 to – 1.329)
a Models used eFI multiplied by 100 to aid estimation and interpretation. Text in results refers to eFI in original units
Fig. 1 Estimated mean trajectories of eFI over 1 year for each of the three latent classes with a random sample of observed individual trajectories
for each class
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Discussion
We have identified a distinct frailty trajectory that is as-
sociated with an increased risk of mortality amongst
older adults. Individuals with rapidly rising frailty (aver-
age monthly rise in eFI of 0.01 or accrual of 0.4 deficits)
are twice as likely to die within 12 months as individuals
with stable frailty. Individuals in this class experience an
initial monthly increase in eFI of 0.02, prior to slowing
around 8–9 months prior to death. This rapidly rising
class represents a small but important proportion of the
population who may not be recognised as being at high
risk of death, as they started from a lower mean baseline
eFI than the rest of the population [17]. The ‘moderately
increasing frailty’ class are also at a greater risk of mor-
tality, with an average rise of 0.005 in eFI per month as-
sociated with a 58% increase in mortality.
Our study demonstrated that, for a small proportion
of the population, significant changes in frailty occur
over 1 year. Individuals with lower levels of frailty who
experience a rapid rise have a greater risk of death over
1 year than individuals with higher, but stable frailty.
The association between severity of frailty measured at
a single time point and risk of mortality has been ro-
bustly demonstrated at the population level [23]. How-
ever, our previous work found that this association did
not translate into a useful measure for predicting indi-
vidual risk of mortality when frailty is measured at a sin-
gle time point, even close to death [18]. Building on
previous work that has examined the relationship be-
tween longitudinal change in frailty and mortality at
yearly intervals [21, 24], we have been able to measure
frailty changes at monthly intervals over the final year of
life. Our findings suggest that some individuals are resili-
ent to higher but stable levels of frailty, and that changes
in frailty status may be a more useful indicator of mor-
tality risk. The positive predictive value and sensitivity
for the rapidly rising trajectory mean that recognition of
this trajectory alone may not be a reliable predictor of
imminent death. However, it may be useful to support
clinical judgement and as a risk stratification tool, espe-
cially as many individuals who follow this trajectory may
not be considered as ‘at risk’ because of their low levels
of baseline frailty. The Q Mortality risk prediction algo-
rithm, which incorporates a frailty index and was de-
signed specifically to assess mortality risk, has better
cross-sectional prediction of mortality than the eFI.
However, the frailty index implemented in Q mortality
does not currently include a weighting for risk based on
changes in frailty scores over time [25].
Strengths and limitations
We have presented a large population-based longitudinal
study of change in frailty measured with the eFI at
monthly intervals. Our analysis used a measure of frailty
that is available to the majority of general practitioners
in England, enhancing the potential for the findings to
be applied in practice. The trajectories have potential
relevance to older populations in other countries, par-
ticularly when frailty is measured using a cumulative
deficit approach. Much previously published work on
frailty has used data from cohort studies, subject to all
the potential limitations of observational research. In
this study, participants were drawn from a large, unse-
lected primary care cohort, demographically and geo-
graphically representative of England’s population, and
data were routinely collected.
However, there were limitations to our approach. First,
the design as implemented at data extraction meant
Table 3 Demographic characteristics of the classes and the proportion of individuals in each class from the age- and sex-adjusted
model reweighted to the population level
n % n Female % Female Reweighted na % Mean age SD Mean eFIb
Total 26,298 – 14,620 55.59 191,584 – – – –
Rapidly rising 583 2.22 327 56.09 2100 1.10 85.81 5.80 0.21
Moderate growth 5571 21.18 3105 55.74 33,225 17.34 85.57 5.88 0.26
Stable 20,144 76.60 11,188 55.54 156,259 81.56 85.34 6.02 0.25
Cases total 13,149 – 7310 55.59 13,149 6.86 – – –
Rapidly rising 415 3.16 241 58.07 415 3.16 85.13 5.92 0.23
Moderate growth 3242 24.66 1743 53.76 3242 24.66 85.21 5.90 0.28
Stable 9492 72.19 5326 56.11 9492 72.19 85.11 6.01 0.27
Controls total 13,149 – 7310 55.59 178,435 93.14 – – –
Rapidly rising 167 1.27 86 51.50 1685 0.94 87.45 5.17 0.18
Moderate growth 2330 17.72 1362 58.45 29,983 16.80 86.08 5.82 0.24
Stable 10,652 81.01 5862 55.03 146,767 82.25 85.54 6.01 0.23
aPosterior probabilities for being in each class were combined with Office of National Statistics-derived population weights to reweight classes to the population level
b Age adjusted
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controls were identified at the end of the study (1 January
2016), then matched to individuals who had died in the
preceding year (matching was at date of death). Follow-up
for the controls was determined from 1 January 2015 to 1
January 2016, but for the cases, follow-up was calculated
for 1 year prior to date of death. Controls were not chosen
at the point of case death, so this created an imbalance in
ages between cases and controls whereby controls were, on
average, 6 months older than cases. However, all analyses
were adjusted for age, and as frailty increases with age,
controls are more likely to have been measured at a higher
point in their frailty trajectory and therefore would attenu-
ate our findings if any residual effect of age remained.
Secondly, because study exclusion criteria were applied
by ResearchOne at the time of data extraction, we do
not have information about the number of people who
were not eligible for inclusion in our analysis. Electronic
health record systems also rely on clinicians recording
their observations correctly using the Read code system,
and we were unable to make any assessment of patterns
of incorrect or differential coding; nevertheless, this is
the same information as used for clinical decisions.
Finally, the way in which eFI is calculated and the data
on which it is based (mostly long-term or irreversible
deficits), means that eFI scores can only increase or re-
main stable. This means that any analysis using eFI
would not be able to capture improvement or recovery
in frailty, which is known to be feasible with interven-
tions such as physical exercise [26–28].
Conclusions
This longitudinal population-based study demonstrates that
it is possible to use a frailty index calculated within elec-
tronic healthcare records to identify people who are at a
higher risk of dying within 1 year. This has potential appli-
cation in health services to support clinicians in identifying
older adults dying with frailty who may have been over-
looked by traditional approaches and to help ensure appro-
priate care is offered. The rapid initial rise in eFI from a low
baseline, followed by a plateau, may be particularly useful
in primary care, promoting recognition of people at risk of
death, but also allowing time for intervention.
Additional file
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Abbreviations
BIC: Bayesian information criterion; CI: Confidence interval; eFI: Electronic
frailty index; GP: General practitioner; NHS: National Health Service; OR: Odds
ratio; SD: Standard deviation; UK: United Kingdom
Acknowledgements
Members of VoiceNorth (a Newcastle University-funded organisation that
aims to capture the public’s views on research and policy developments)
were involved in this research. A number of them had been caregivers for a
relative or friend at the end of life. Their views helped to shape the research
question, and will help us to develop a plain language summary for wider
dissemination.
Funding
This work was supported by the National Institute for Health Research (NIHR)
School for Primary Care Research (SPCR, 2016DS to DS) and the Medical
Research Council (MC_U105292687 to FEM). The views expressed are those
of the authors and not necessarily those of the NHS, the NIHR or the
Department of Health. The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Availability of data and materials
The data that support the findings of this study are available from
ResearchOne, but restrictions apply to the availability of these data, which
were used with appropriate permissions for the current study, and so are not
publicly available. Data are not available from the authors because they
relate to real and current NHS health records, and the authors do not have
permission to share these data.
Authors’ contributions
BH and FEM designed the study and obtained the data, DS undertook the
analysis supervised by FEM and wrote the first draft of the paper, all authors
edited the paper and agree with the text. DS is guarantor of the analysis.
Ethics approval and consent to participate
Approval for this study was granted by the ResearchOne ethical review
panel with oversight from the UK NHS Health Research Authority and the UK
Government Health and Social Care Information Centre Confidentiality
Advisory Group. ResearchOne was approved by the UK National Health




The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Received: 30 April 2018 Accepted: 6 August 2018
References
1. Collard RM, Boter H, Schoevers RA, Oude Voshaar RC. Prevalence of frailty in
community-dwelling older persons: a systematic review. J Am Geriatr Soc.
2012;60(8):1487–92.
2. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people.
Lancet. 2013;381(9868):752–62.
3. Morley JE, Vellas B, Abellan van Kan G, Anker SD, Bauer JM, Bernabei R, et al.
Frailty consensus: a call to action. J Am Med Dir Assoc. 2013;14(6):392–7.
4. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al.
Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med
Sci. 2001;56(3):M146–56.
5. Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J
Gerontol A Biol Sci Med Sci. 2007;62(7):722–7.
6. Theou O, Brothers TD, Mitnitski A, Rockwood K. Operationalization of frailty
using eight commonly used scales and comparison of their ability to
predict all-cause mortality. J Am Geriatr Soc. 2013;61(9):1537–51.
7. Drubbel I, de Wit NJ, Bleijenberg N, Eijkemans RJ, Schuurmans MJ, Numans
ME. Prediction of adverse health outcomes in older people using a frailty
index based on routine primary care data. J Gerontol A Biol Sci Med Sci.
2013;68(3):301–8.
Stow et al. BMC Medicine  (2018) 16:171 Page 6 of 7
8. Hope AA, Gong MN, Guerra C, Wunsch H. Frailty before critical illness and
mortality for elderly Medicare beneficiaries. J Am Geriatr Soc. 2015;63(6):
1121–8.
9. Jenq G, Tinetti ME. Changes in end-of-life care. JAMA. 2015;309:489–90.
10. Eynon T, Lakhani MK, Baker R. Never the right time: advance care planning
with frail and older people. Br J Gen Pract. 2013;63:511–2.
11. National Institute for Health and Care Excellence. NICE Quality Standard 13:
End of Life Care for Adults. London: NICE; 2017.
12. Dixon J, King D, Matosevic T, Clark M, Knapp M. Equity in the Provision of
Palliative Care in the UK: Review of Evidence. Personal Social Services
Research Unit: London School of Economics. 2015. https://www.pssru.ac.uk/
pub/4962.pdf. Accessed 1 Feb 2018.
13. Cohen-Mansfield J, Skornick-Bouchbinder M, Brill S. Trajectories of end of
life: a systematic review. J Gerontol B. 2018;73(4);564–72.
14. Cardona-Morrell M, Lewis E, Suman S, Haywood C, Williams M, Brousseau
AA, et al. Recognising older frail patients near the end of life: what next?
Eur J Intern Med. 2017;45:84–90.
15. Tapsfield J, Hall C, Lunan C, McCutcheon H, McLoughlin P, Rhee J, et al.
Many people in Scotland now benefit from anticipatory care before they
die: an after death analysis and interviews with general practitioners. BMJ
Support Palliat Care. 2016;(0):1–10. https://doi.org/10.1136/bmjspcare-2015-
001014.
16. Moody D, Lyndon H, Stevens G. Toolkit for General Practice in Supporting
Older People Living with Frailty. Leeds: NHS England; 2017.
17. Clegg A, Bates C, Young J, Ryan R, Nichols L, Ann Teale E, et al.
Development and validation of an electronic frailty index using routine
primary care electronic health record data. Age Ageing. 2016;45(3):353–60.
18. Stow D, Matthews FE, Barclay S, Iliffe S, Clegg A, De Biase S, et al. Evaluating
frailty scores to predict mortality in older adults using data from population
based electronic health records: case control study. Age Ageing. 2018;47(4);
564-69.
19. Hsu HC, Chang WC. Trajectories of frailty and related factors of the older
people in Taiwan. Exp Aging Res. 2015;41(1):104–14.
20. Marshall A, Nazroo J, Tampubolon G, Vanhoutte B. Cohort differences in the
levels and trajectories of frailty among older people in England. J Epidemiol
Community Health. 2015;69:316–21.
21. Chamberlain AM, Finney Rutten LJ, Manemann SM, Yawn BP, Jacobson DJ,
Fan C, et al. Frailty trajectories in an elderly population-based cohort. J Am
Geriatr Soc. 2016;64(2):285–92.
22. Lanza ST, Tan X, Bray BC. Latent class analysis with distal outcomes: a
flexible model-based approach. Struct Equ Modeling. 2013;20(1):1–26.
23. Kojima G, Iliffe S, Walters K. Frailty index as a predictor of mortality: a
systematic review and meta-analysis. Age Ageing. 2018;47(2):193–200.
24. Buchman AS, Wilson RS, Bienias JL, Bennett DA. Change in frailty and risk of
death in older persons. Exp Aging Res. 2009;35(1):61–82.
25. Hippisley-Cox J, Coupland C. Development and validation of QMortality risk
prediction algorithm to estimate short term risk of death and assess frailty:
cohort study. BMJ. 2017;358:j4208.
26. Clegg AP, Barber SE, Young JB, Forster A, Iliffe SJ. Do home-based exercise
interventions improve outcomes for frail older people? Findings from a
systematic review. Rev Clin Gerontol. 2012;22(1):68–78.
27. Puts MTE, Toubasi S, Andrew MK, Ashe MC, Ploeg J, Atkinson E, et al.
Interventions to prevent or reduce the level of frailty in community-
dwelling older adults: a scoping review of the literature and international
policies. Age Ageing. 2017;46(3):383–92.
28. Rogers NT, Marshall A, Roberts CH, Demakakos P, Steptoe A, Scholes S.
Physical activity and trajectories of frailty among older adults: evidence from
the English longitudinal study of ageing. PLoS One. 2017;12(2):e0170878.
Stow et al. BMC Medicine  (2018) 16:171 Page 7 of 7
